MD Anderson Spent at Least $62 Million on an AI It Never Tested Outside the Building
Article summary
Quick briefing — cleaned from the original RSS feed
The improvement you measured is a covariance, not a cause In 2013, MD Anderson Cancer Center began building a clinical decision support tool with IBM, using Watson technology. It was called the Oncology Expert Advisor. It was supposed to recommend treatments, match patients to trials, and help evaluate cases. Over roughly four years the project consumed at least $62 million. By September 2016 it was not in clinical use. IBM ended support for the pilot and demo systems effective September 1 of…
1Key Takeaways
- The improvement you measured is a covariance, not a cause In 2013, MD Anderson Cancer Center began building a clinical decision support tool with IBM, using Watson technology.
- It was called the Oncology Expert Advisor.
- It was supposed to recommend treatments, match patients to trials, and help evaluate cases.
- Over roughly four years the project consumed at least $62 million.
2AIWedia Score
8.5/10
High relevance — worth your attention today
Based on source trust, recency, category impact, and story depth.
3Why it matters
Coding AI shifts how fast software ships and how much human review each change needs. DEV — ML reports that the improvement you measured is a covariance, not a cause In 2013, MD Anderson Cancer Center began building a clinical decision support tool with IBM, using Watson technology.
Explore related
Browse toolsCoding AI news
Explore curated coding ai tools on AIWedia — compare, rank, and launch from our directory.
Full story on DEV — ML
Read full articleHeadlines aggregated via RSS for discovery on AIWedia. Original content © DEV — ML. We link to the source and do not republish full articles.